Medvantx Announces the Internal Appointment of Micah Benford

Medvantx Announces the Internal Appointment of Micah Benford

Medvantx, pharmacy services provider, today announced the appointment of Micah Benford to chief pharmacy officer of Medvantx Pharmacy Services. As chief pharmacy officer, Micah is responsible for the planning, design, operation, and improvement of Medvantx’s mail order pharmacy management and operations.

“The pandemic has heightened consumers’ desire to have products and services delivered directly to their doors,” said Jeremy V. Gross, CEO of Medvantx. “Medvantx is at a critical stage of growth as we continue to build our innovative final-mile fulfillment services to give manufacturers the ability to reach patients faster. With over two decades of pharmacy operations experience, Micah understands the logistical, clinical, and financial needs of a successful pharmacy, as well as consumers’ evolving preferences, making him the perfect team member for this role.”

In this new position, Micah will oversee Medvantx’s role in the ever-changing healthcare environment, identifying emerging trends that impact the company’s customers. He will be responsible for assessing healthcare-related discoveries to ensure the value of pharmacy and pharmacists is advocated for and advanced in the company’s overall efforts to improve patient care. He will oversee the design, implementation, and management of a safe and effective medication management organization, ensuring systems are developed and improved based on evidence and best practices and that they operate effectively and efficiently across the continuum of care.

“Medvantx has a long history of pharmacy success in the direct-to-patient space and, alongside our new sister company, Vytal, we are well-positioned to bring innovative solutions to patient care across the nation,” said Micah. “I am honored and excited to lead Medvantx as the next chief pharmacy officer, and to continue redefining pharmacy.”

Prior to Medvantx, Micah served as a specialty pharmacist at KnippeRx, an independent specialty pharmacy focused on speed to therapy in rare, orphan, ultra-orphan, and high-touch biologic therapies. He has also held several director of pharmacy roles, where he was responsible for all aspects of pharmacy operations.

About Medvantx, Inc.

Medvantx Pharmacy Services helps pharmaceutical brands do more than just survive in an ever-changing marketplace – we help them thrive in it. Medvantx provides powerful and personalized support to pharmaceutical manufacturers, health care providers (HCPs), and their patients. We service the specialty needs of pharmaceutical manufacturers by offering patient assistance programs and providing efficient intake solutions, nationwide dispense and fulfillment services, quality aftercare through counseling and customer service, safe and secure data handling, dependable inventory management and logistics, and insightful reporting and accounting. Serving more than 50 pharmaceutical manufacturers and managing more than $7.5 billion of prescriptions annually, Medvantx has been redefining pharmacy for over 20 years.

Medvantx contact:

Michael Melvin
(267) 353-5725
michael.melvin@medvantx.com

Source:
Medvantx, Inc.

Related Links:
www.medvantx.com

Medvantx Pharmacy at UPS Louisville Facility Completes Significant Expansion

Medvantx Pharmacy at UPS Louisville Facility Completes Significant Expansion to Meet Increasing Demand for Direct-to-Patient Prescription Orders

Medvantx ‘end of runway’ fulfillment operations within UPS Supply Chain Solutions campus has surpassed $3.7 billion in pharmaceutical inventory management

San Diego, January 13, 2020 – Medvantx, Inc., a leading provider of ecommerce pharmacy and final-mile delivery solutions, today announced a major expansion and technology upgrades of its embedded, end-of-runway pharmacy at the UPS Supply Chain Solutions campus in Louisville, KY. The expansion doubles Medvantx’s pharmacy space to support the company’s continued growth; Medvantx recently surpassed $3.7 billion in pharmaceutical inventory management annually.

The location of the Medvantx end-of-runway pharmacy, adjacent to the UPS Worldport® global air hub, enables the company to fill prescriptions and ship medicines for expedited delivery to patients or doctors’ offices via the UPS air network. With an order cutoff time of 1AM ET, Medvantx has one of the industry’s most comprehensive shipping capabilities.

“As Medvantx undergoes tremendous growth, an agile, scalable and best-in-class supply chain is absolutely critical,” said Robert J Feeney, Jr., CEO of Medvantx. “Our pharmacy services at UPS Supply Chain Solutions, combined with our innovative relationship with UPS staff, help provide Medvantx with the resources needed to meet consumer expectations for more rapid, on-time delivery of medications.”

Medvantx’s expanded pharmacy space is fully licensed and cGMP-compliant, and supports a full range of distribution and warehousing services — including secured storage, packaging and labeling — for temperature-sensitive healthcare products such as specialty pharma and controlled substances.

“Direct-to-patient services are a growing trend,” said Wes Wheeler, president of UPS Healthcare and Life Sciences. “We are pleased to help customers like Medvantx meet specialized, priority needs for critical therapies with a robust supply chain that enables better health and business growth.”

“Speed to therapy can be a significant contributor to patient engagement and adherence, especially for patients beginning a new drug regimen,” Feeney added. “One of our goals at Medvantx is to increase our fulfillment and delivery speed to foster greater adherence for patients.”

About Medvantx, Inc. Medvantx, Inc., partners with pharmaceutical and biopharmaceutical companies to bring medicines to patients with a direct-to patient platform that streamlines delivery, minimizes cost and enhances the patient experience. Managing the entire process from end to end, Medvantx offers e-commerce solutions, pharmacy services and innovative final-mile fulfillment. Licensed

in all 50 states and handling more than $7.5 billion in prescriptions annually, Medvantx has been redefining pharmacy for over 15 years.

###

Medvantx contact:

Michael Melvin
(267) 353-5725
michael.melvin@medvantx.com

Source:
Medvantx, Inc.

Related Links:
www.medvantx.com

Medvantx Adds Chief Technology Officer to its Senior Management Team

Medvantx Adds Chief Technology Officer to its Senior Management Team

SAN DIEGO, Tuesday, January 07, 2020 –Medvantx, Inc., the leading provider of ecommerce and final mile delivery solutions, announces that Jeremy (“Jerry”) V. Gross has joined the company as Chief Technology Officer (CTO). This newly created position will focus on the further development of the company’s proprietary ecommerce, pharmacy and final mile delivery platform.

“Jerry’s unique combination of expertise from the financial technology sector pharmaceutical and logistics industries, is a key addition to Medvantx, and will help our customers navigate a rapidly changing healthcare marketplace,” said Robert J Feeney, Jr., founder and CEO of Medvantx.

Gross brings a 30+ year track record of leading development teams and leveraging emerging technologies to create disruptive innovation within biopharma, healthcare and the financial technology industries. Previously, he held senior technology, innovation and incubation leadership roles at Amgen, McKesson, Intuit and JPMorgan. Gross has lead the design, development and commercialization of e-commerce, complex back-end logistics systems and cloud-based data solutions for pharmaceutical and global distribution companies, as well as early online banking and e-Commerce platforms in financial services.

“Medvantx is one of the early pioneers in the direct-to-patient space and has the experience and infrastructure necessary to support large scale digital transformation strategies for pharmaceutical companies,” said Jerry Gross, chief technology officer at Medvantx. “I’m thrilled to join the Medvantx team, and to work with leading developers and technology partners to identify and pilot emerging technologies in consumer engagement, machine learning and big data to bring advances to the healthcare industry.”

As CTO, Gross will lead Medvantx newly created business unit dedicated to advancing the company’s technology platform, and identify new technology-based solutions for the company’s clients. This business unit will be located in San Diego to encourage collaboration with the local digital healthcare and technology community.

About Medvantx, Inc.

Medvantx, Inc., partners with pharmaceutical and biopharmaceutical companies to bring medicines to patients with a direct-to patient platform that streamlines delivery, minimizes cost and enhances the patient experience. Managing the entire process from end to end, Medvantx offers e-commerce solutions, pharmacy services and innovative final-mile fulfillment. Licensed in all 50 states and handling more than $7.5 billion in prescriptions annually, Medvantx has been redefining pharmacy for over 15 years.

Medvantx contact:

Michael Melvin
(267) 353-5725
michael.melvin@medvantx.com

Source:
Medvantx, Inc.

Related Links:
www.medvantx.com